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Received November 26, 2013; accepted March 11, 2014AbstractBackground: In the population-based Shihpai Eye Study, patients aged >65 years with myopic maculopathy were found to have higher systolic
blood pressure. This finding deserved further exploration because this is the only correctable factor for preventing maculopathy in patients with
high myopia. Therefore, we investigated the association between myopic maculopathy and systolic blood pressure, as well as other ocular
parameters in this study.
Methods: A clinic-based, retrospective cross-sectional study at a medical center was conducted between February 2011 and October 2012.
Patients with high myopia were included and medical charts were reviewed. High myopia was defined as axial length 26.5 mm in at least one
eye. Myopic maculopathy was defined as the presence of lacquer cracks, focal areas of deep choroidal atrophy, diffuse chorioretinal atrophy, and
macular choroidal neovascularization or geographic atrophy in the presence of high myopia. Systolic blood pressure measurements were
collected, and fundus photography and optical coherence tomography were performed. Subfoveal choroidal thickness (SFCT) shown on optical
coherence tomography was measured and recorded.
Results: The medical records of 187 high-myopic patients (87 without and 100 with maculopathy) were reviewed. Patients with maculopathy
were older (56.96 years vs. 42.95 years, p < 0.01), had longer axial length (29.96 mm vs. 27.31 mm, p < 0.01), thinner SFCT (49.71 mm vs.
155.77 mm, p < 0.01), higher systolic blood pressure (132.28 mmHg vs. 125.31 mmHg, p < 0.05), greater prevalence of hypertension (31% vs.
16%, p < 0.05), and longer history of hypertension (2.34 years vs. 0.59 years, p < 0.01) compared to patients without maculopathy. After
multivariate adjustment, SFCT and axial length were the only significant factors for maculopathy.
Conclusion: Thinner SFCT and longer axial length are significant risk factors for myopic maculopathy. Unlike previous epidemiological surveys,
results of this clinic-based study suggested that systolic blood pressure is not a significant factor for maculopathy.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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The prevalence of myopia is increasing worldwide and has
become an extensive public health problem, especially in East
Asian countries.1e5 Among myopia, high myopia, also termed
“pathologic myopia” or “degenerative myopia”, is associated
with multiple ocular morbidities. One of the most important
complications of high myopia is myopic maculopathy, which
often causes significant visual impairment.6 The signs ofociation. All rights reserved.
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retina, posterior staphyloma, lacquer cracks, patchy atrophy,
choroidal neovascularization (CNV), and geographic atrophy.7
Clinic-based studies have shown that increased severity of
maculopathy is associated with increased axial length and
age.8,9
In the population-based Shihpai Eye Study, patients aged
>65 years with myopic maculopathy were found to have
higher systolic blood pressure after multivariate adjustment
including age and other systemic factors.10 Higher systolic
blood pressure is associated with thinner choroidal thickness
in normal individuals,11,12 therefore, the authors suggested that
increased systolic blood pressure may play a role in the
pathogenesis of maculopathy by decreasing choroidal circu-
lation from the back of the eye.10 However, that study had a
small sample size and important ocular parameters such as
axial length and choroidal thickness were not analyzed. This
finding deserved further exploration because systolic blood
pressure might be the only correctable factor for preventing
maculopathy in patients who already have high myopia. The
purpose of the present study was to clarify the risk factors
associated with myopic maculopathy in a clinic-based study
with more complete data, namely systolic blood pressure,
axial length, choroidal thickness, and age.
2. Methods2.1. PatientsThis was a clinic-based, retrospective cross-sectional study
that reviewed the medical records of 187 highly myopic
Chinese patients from February 2011 to October 2012 at the
Medical Center, Taipei Veterans General Hospital, Taipei,
Taiwan. The Institutional Review Board approved the pro-
tocols of this study prior to initiation. High myopia was
defined as axial length 26.5 mm. Myopic maculopathy was
defined as the presence of lacquer cracks, focal areas of deep
choroidal atrophy, and macular CNVor geographic atrophy in
the presence of high myopia.10 When eyes of a patient were
discrepant for the severity of myopic maculopathy, the more
severe eye was assigned for the study. However, if the more
severe eye had any retinal disorder other than myopic mac-
ulopathy or foveoschisis, or had ever received ocular surgery
other than intravitreal injection and cataract surgery, the less
severe eye was assigned. Eyes with macular pucker, diabetic
retinopathy, age-related macular degeneration, retinal vein
occlusion, retinal artery occlusion, retinal detachment, and
eyes that had ever received vitrectomy and scleral buckling
were excluded.Fig. 1. SFCT is measured from Bruch's membrane to the sclera at the center of2.2. Ophthalmic examinations
the fovea perpendicular to the Bruch's membrane plane. The image color was
changed to increase the contrast between the choroid and the sclera. (A) OCT
of a 32-year-old woman without maculopathy. The axial length is 26.62 mm
and SFCT is 140 mm (as shown by the white line). (B) OCT of a 41-year-old
man with myopic maculopathy. His axial length is 30.34 mm and SFCT is
63 mm (as shown by the white line). OCT ¼ optical coherence tomography;
SFCT ¼ subfoveal choroidal thickness.Ophthalmic examinations included measurements of visual
acuity with Snellen charts at a distance of 6 m, autorefraction
(RK-8100; Topcon, Tokyo, Japan), non-contact tonometry
(CT-60; Topcon), slit-lamp biomicroscopy (Model BQ900;
Haag-Streit, Bern, Switzerland), and indirect ophthalmoscopy(Model 12500; Welch Allyn, Skaneateles Falls, NY, USA)
through a dilated pupil with 1% tropicamide (Alcon, Couv-
reur, Puurs, Belgium). Lens status was recorded as phakic,
pseudophakic, and aphakic. In addition, ultrasound biometry
(AL-1000; Tomey Corporation, Aichi, Japan) was performed
in all patients. Both eyes of each participant were photo-
graphed using a monoscopic fundus camera (CF-60UD;
Canon, USA) at least 30 minutes after pupil dilatation. Two
photographic fields were taken in each eye, with one centered
at the fovea and the other at the optic disc. Optical coherence
tomography (OCT) imaging of both eyes was performed using
RTVue OCT (Optovue Inc., Fremont, CA, USA). Subfoveal
choroidal thickness (SFCT) was measured using the calipers
within the OCT machine software and positioning them from
the outer aspect of Bruch's membrane to the border of the
sclera.11 With the participant in a seated position, blood
pressure was measured in the right arm using an electronic
sphygmomanometer (ES-P2000; Terumo, Japan) and the
average of at least three measurements was recorded. History
of hypertension, diabetes mellitus, stroke, and cardiovascular
disease was defined as a positive medical record and treatment
with medications for such conditions.2.3. OCT imagingRTVue OCT uses the technology of spectral-domain OCT.
The scanning pattern was set to produce a cross-line scan that
obtained 16 individual B scans of 1024 pixels each at the same
location for a total of 16,384 data points per line. The B scan
was viewed as an averaged composite image that reduced
OCT noise and enhanced the image sharpness. The SFCT was
measured at the center of the fovea in the horizontal and
vertical line pattern (Fig. 1). The horizontal data13 were used
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images, the vertical data were used.2.4. Statistical analysisThe significance of the differences between characteristics
reported as mean values in patients with or without myopic
maculopathy was assessed using the t test. The c2 test was
used to assess the significance of differences between char-
acteristics expressed as proportions in patients with or without
myopic maculopathy. Logistic regression was used to examine
the relationships between myopic maculopathy and the
selected characteristics. Pearson's correlation coefficient was
used to measure the strength and direction of the linear rela-
tionship between two variables. Statistical analyses were
performed with commercially available software (SPSS
version 19.0; SPSS Inc., Chicago, IL, USA).
3. Results3.1. Univariate and multivariate analyses of ocular
characteristics in high-myopic eyes with or without
maculopathyRecords from 187 high myopic patients (87 without and
100 with maculopathy) were included in the analyses. De-
mographic, ocular, and systemic data of the included patients
grouped by presence of maculopathy are summarized in
Table 1. There were five asymmetric cases with high myopia
in only one eye. However, the following results did not change
even after excluding these five cases. Patients withTable 1
Univariate and multivariate analyses of ocular parameters and risk factors in high
Parameter Univariate
Without maculopathy
(n ¼ 87)
With maculopathy
(n ¼ 100)
Ageb (y) 42.95 ± 15.06 56.96 ± 12.89
Sexc (M/F) 27/60 22/78
VAa,b (logMAR) 0.10 ± 0.21 0.60 ± 0.60
Lensc (P/PS/A) 65/19/3 84/14/2
ALb (mm) 27.31 ± 1.67 29.96 ± 1.95
SFCTb (mm) 155.77 ± 79.13 49.71 ± 34.29
SBPb (mmHg) 125.31 ± 21.07 132.28 ± 19.13
DBPb (mmHg) 78.13 ± 13.93 79.23 ± 11.12
HTN (y)b 0.59 ± 2.08 2.34 ± 4.91
HTN historyc 14/87 31/100
DMc 6/87 7/100
Smokingc 2/87 1/100
CV diseasec 6/87 9/100
Strokec 0/87 1/100
Data are presented as mean ± standard deviation.
AL ¼ axial length; CI ¼ confidence interval; CV disease ¼ cardiovascul
HTN ¼ hypertension; Lens (P/PS/A) ¼ Lens (phakia/pseudophakia/aphakia); OR
thickness; VA ¼ visual acuity.
The p values in bold font indicate statistical significance.
*A p value <0.05 was considered statistically significant.
a Visual acuity was checked with Snellen chart and transformed to logMAR dat
b t test.
c c2 test.maculopathy were older (56.96 years vs. 42.95 years,
p < 0.01), had poorer corrected visual acuity (logMAR: 0.60
vs. 0.10, p < 0.01), longer axial length (29.96 mm vs.
27.31 mm, p < 0.01), thinner SFCT (49.71 mm vs. 155.77 mm,
p < 0.01), and higher systolic blood pressure (132.3 mmHg vs.
125.3 mmHg, p < 0.05) compared with patients without
maculopathy. Overall, 24% (45/187) of the patients had a
positive history of hypertension (31% vs. 16% in patients with
and without maculopathy, respectively, p < 0.05). In patients
who had a history of hypertension, patients with maculopathy
had longer history of hypertension than patients without
maculopathy (2.34 years vs. 0.59 years, respectively,
p < 0.01). We also found that patients with a history of hy-
pertension had higher blood pressure than those without hy-
pertension (systolic blood pressure: 143 mmHg vs.
124.5 mmHg, p < 0.01). Patients with a history of hyperten-
sion had higher systolic blood pressure measured in the hos-
pital even if they had antihypertensive medication. However,
after multivariate adjustment by logistic regression, positive
history and duration of hypertension, as well as systolic blood
pressure, were no longer significantly different between pa-
tients with and without myopic maculopathy (Table 1). SFCT
(odds ratio ¼ 0.977, p < 0.01) and axial length (odds
ratio ¼ 1.686, p < 0.01) were the two significant factors for
myopic maculopathy after multivariate adjustment.3.2. Relationships of age, axial length, SFCT, and
systolic blood pressureIn these high-myopic patients, SFCT was negatively
correlated with axial length (r ¼ 0.61, p < 0.01; Fig. 2A),-myopic eyes with or without maculopathy.
Multivariate
p* OR 95% CI for OR p*
Lower Upper
< 0.001 1.03 0.98 1.09 0.196
0.161
< 0.001
0.288
< 0.001 1.69 1.19 2.39 0.003
< 0.001 0.98 0.96 0.99 0.001
0.020 0.99 0.97 1.03 0.943
0.551
0.003 1.10 0.87 1.40 0.421
0.017 0.72 0.13 4.07 0.707
0.978
0.598
0.597
> 0.99
ar disease; DBP ¼ diastolic blood pressure; DM ¼ diabetes mellitus;
¼ odds ratio; SBP ¼ systolic blood pressure; SFCT ¼ subfoveal choroidal
a.
Fig. 2. Pearson correlation showing negative correlation between: (A) subfoveal choroidal thickness and axial length (r ¼ 0.61, p < 0.01); (B) age (r ¼ 0.55,
p < 0.01); (C) systolic blood pressure (r ¼ 0.16, p < 0.05).
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(r ¼ 0.16, p < 0.05; Fig. 2C). However, after linear
regression, only age and axial length contributed to the vari-
ance of SFCT (21.6% and 36.5%, respectively). In addition,
age was positively correlated with systolic blood pressure
(r ¼ 0.38, p < 0.01; Fig. 3A) and axial length (r ¼ 0.19,
p < 0.01; Fig. 3B). After stepwise analysis with logistic
regression hierarchically as shown in Table 2, systolic blood
pressure was no longer a significant factor after adding age as
a factor into the model, suggesting that the effect of increased
blood pressure on maculopathy was no greater than the effect
of age.
4. Discussion
Our results showed that myopic maculopathy was mostly
associated with decreased SFCT and increased axial length.
These results were consistent with the study of Wang et al,14
showing choroidal thickness was the most significant predic-
tive factor for lacquer cracks. A thinner choroidal vascular
complex may compromise blood flow, which can result in the
development of lacquer cracks. Moreover, lacquer cracks may
extend the area of choriocapillary atrophy as well as increaseFig. 3. Pearson correlation showing positive correlation between (A) age and systolithe chances of CNV ingrowth from a ruptured Bruch's mem-
brane.15,16 When removing the factor of SFCT in multivariate
adjustment analysis, we found age and axial length were still
significant factors for maculopathy, as in previous studies.8,9
We also found that SFCT was correlated with axial length
and age. Aging and increased axial length together would
make the choroid vascular complex become thinner, which
increases the risk of myopic maculopathy.
In our study, although systolic blood pressure was associ-
ated with myopic maculopathy, it was no longer a significant
factor after multivariate adjustment. In the population-based
Shihpai Eye Study, patients aged >65 years with myopic
maculopathy were found to have higher systolic blood pres-
sure after multivariate adjustment, including age and other
systemic factors.10 The authors proposed that high systolic
blood pressure may compromise the thinner choroid in highly
myopic patients, increasing the severity of maculopathy.
However, choroidal thickness was not available and axial
length was not used for multivariate adjustment in the Shihpai
Eye Study. Also, the age range was limited to elderly patients
in that study.
Our study had several limitations. First, a selection bias
may have existed because all included patient records werec blood pressure (r ¼ 0.38, p < 0.01) and (B) axial length (r ¼ 0.19, p < 0.01).
Table 2
Hierarchical regression analysis of factors associated with myopic maculop-
athy which includes step-wise adding of SBP, age, axial length and SFCT.a
Parameter Step 1 beta Step 2 beta Step 3 beta Step 4 beta
SBP 0.018* 0.000 0.05 0.004
Age 0.071*** 0.096*** 0.035
AL 0.895*** 0.518**
SFCT .023**
Variance
explained
(R2)
0.040 0.258 0.608 0.670
R2 change 0.040 0.254 0.35 0.062
*p < 0.05 for beta value.
**p < 0.01 for beta value.
***p < 0.001 for beta value.
AL ¼ axial length; SBP ¼ systolic blood pressure; SFCT ¼ subfoveal
choroidal thickness.
a The explained variance for myopic maculopathy ranged from 0.04 of SBP
alone to 0.67 with all factors adjusted.
Table 3
Ocular characteristics and other parameters in patients >65 years of age with
maculopathy compared with those with maculopathy in the Shihpai Eye Study.
Parameter Patients in current
study (n ¼ 22)
Shihpai Eye Study
patients (n ¼ 32)
p
Age (y) 74.14 ± 8.10 74.31 ± 6.62 0.930
Sex (male) 27.27 50.00 0.095
Positive hypertension
history
54.55 46.88 0.580
Systolic blood pressure
(mmHg)
140.91 ± 22.67 146.44 ± 16.20 0.305
Axial length (mm)a 29.85 ± 1.95 28.27 ± 2.08 0.037
M3/M4/M5 (no.)a 3/4/15 7/8/17 0.535
Data are presented as mean ± SD or % unless otherwise indicated.
M3 ¼ lacquer cracks; M4 ¼ patchy atrophy or diffuse atrophy;
M5 ¼ geographic atrophy or choroidal neovascularization.
a Only the more severe eye was included in each person in the current and
Shihpai Eye studies.
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bias, the differences in demographics and ocular parameters
between the elderly patients (65 years) in this clinic-based
study and those of the population-based Shihpai Study were
examined (Table 3). Patients in the current study had a com-
parable degree of maculopathy ( p ¼ 0.535), percentage of
positive hypertension history (54.5% vs. 46.9%, p ¼ 0.580),
and blood pressure (141 mmHg vs. 146 mmHg, p ¼ 0.305)
with the population-based Shihpai Study. The axial length,
however, was longer in the current study (29.85 mm vs.
28.27 mm, p ¼ 0.037). These findings suggest that the se-
lection bias in the current study was minimal. Second, we used
a strict definition of high myopia (axial length 26.5 mm) for
phakic or aphakic eyes. However, the cutoff was adopted in
several studies.8,10,17
In conclusion, thinner SFCT and longer axial length were
the two most important risk factors for myopic maculopathy in
this study. After multivariate adjustment, age and systolicblood pressure were not significant factors for maculopathy.
Longitudinal studies are warranted to clarify the relationship
between blood pressure and maculopathy.
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